All In Biotech

Drug Trial Radar · NCT00658528

Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD)

A Randomized Double-Blind Parallel Study of Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD)

Last checked: Nov 20, 2026Latest source record: Dec 21, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,061 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,061

Actual

Start

Feb 2008

Primary completion

Sep 2009

Study completion Jan 2010

Sponsor

Lead sponsor
Eisai Inc.Eisai
Sponsor type
Industry
First posted
Apr 15, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine the safety and efficacy of Rabeprazole extended release (ER) 50 mg versus Esomeprazole 40 mg for healing and symptomatic relief among subjects with erosive gastroesophageal reflux disease (GERD).

Conditions

  • Gastroesophageal Reflux Disease (GERD)

Interventions

  • Rabeprazole sodiumDrug

    Rabeprazole ER 50 mg capsule, taken orally, once daily for 4-8 weeks.

  • EsomeprazoleDrug

    Esomeprazole 40 mg capsule, taken orally, once daily for 4-8 weeks.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants With Erosive Gastroesophageal Reflux Disease (eGERD) Who Achieved Endoscopically-confirmed Healing by 8 WeeksTime frame: Baseline and Week 8
  2. Percentage of Participants With eGERD Who Achieved Endoscopically-confirmed Healing by 4 WeeksTime frame: Baseline and Week 4

Locations

88 sites in 13 countries. Site status is shown where the registry gives one.

  • Site not named

    Anaheim, California

  • Site not named

    Isidro Casanova, La Matanza, BUE, Argentina

  • Site not named

    Ramos Mejía, BUE, Argentina

  • Site not named

    San Isidro, BUE, Argentina

  • Site not named

    Capital Federal, CBA, Argentina

  • Site not named

    Mendoza, MEN, Argentina

  • Site not named

    Rosario, SFE, Argentina

  • Site not named

    Rosario, SFE, Argentina

  • Site not named

    Rosario, SFE, Argentina

  • Site not named

    San Juan, SJN, Argentina

  • Site not named

    Five Dock, New South Wales, Australia

  • Site not named

    Carina Heights, Queensland, Australia

  • Site not named

    Kippa-Ring, Queensland, Australia

  • Site not named

    Box Hill, Victoria, Australia

  • Site not named

    Frankston, Victoria, Australia

  • Site not named

    Malvern, Victoria, Australia

  • Site not named

    Plovdiv, Bulgaria, Bulgaria

  • Site not named

    Sofia, Bulgaria, Bulgaria

  • Site not named

    Sofia, Bulgaria, Bulgaria

  • Site not named

    Sofia, Bulgaria, Bulgaria

  • Site not named

    Sofia, Bulgaria, Bulgaria

  • Site not named

    Stara Zagora, Bulgaria, Bulgaria

  • Site not named

    Varna, Bulgaria, Bulgaria

  • Site not named

    Saint John, New Brunswick, Canada

  • Site not named

    St. John's, Newfoundland and Labrador, Canada

  • Site not named

    Guelph, Ontario, Canada

  • Site not named

    Hamilton, Ontario, Canada

  • Site not named

    Newmarket, Ontario, Canada

  • Site not named

    Toronto, Ontario, Canada

  • Site not named

    Windsor, Ontario, Canada

  • Site not named

    Montreal, Quebec, Canada

  • Site not named

    Montreal, Quebec, Canada

  • Site not named

    Pointe-Claire, Quebec, Canada

  • Site not named

    Québec, Quebec, Canada

  • Site not named

    Québec, Quebec, Canada

  • Site not named

    Saskatoon, Saskatchewan, Canada

  • Site not named

    Santiago, Chile, Chile

  • Site not named

    Vioa Del Mar, Chile, Chile

  • Site not named

    Rijeka, Croatia, Croatia

  • Site not named

    Zagreb, Croatia, Croatia

Showing 40 of 88 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.